Inspire Upper Airway Stimulation System for Obstructive Sleep Apnea: Post Approval Study

  • STATUS
    Recruiting
  • participants needed
    10
Send
Updated on 19 February 2024

Summary

Patients with Obstructive Sleep Apnea (OSA) who are interested in pursuing surgical treatment may be candidates for the Inspire device, an FDA-approved upper airway stimulation device that can help to treat OSA. This trial is collecting long-term safety and efficacy data in participants that are implanted with the Inspire device.

Description

The purpose of this study is to obtain additional long-term safety and efficacy data on the use of Inspire therapy. The study will be conducted in a post-market environment for the treatment of moderate to severe Obstructive Sleep Apnea (OSA) (20≤AHI≤65) in subjects who have been confirmed to fail or cannot tolerate positive airway pressure (PAP) treatments. Subjects meeting all baseline and pre-screening requirements will be implanted with the Inspire system. The Inspire implant process is conducted clinically through the patient's insurance plan. One-hundred and twenty-seven (127) study subjects will be implanted at up to 20 investigational sites in the United States. Subjects will be evaluated at baseline, implant, 1-, 2-, 6- and 12- months post-implant, and bi-annually thereafter through 5 years of post-implant follow-up. Evaluations include questionnaires, medical history evaluation, and evaluation of effect of the Inspire treatment on the patient's sleep apnea. A single night in-lab Polysomnography (PSG) sleep study will be conducted at baseline, and at the 1 and 3 year follow ups. Two night home sleep testing (HST) will be conducted at the 2, 4, and 5 year follow ups. Compensation will be provided for time and travel for research visits.

Details
Condition Obstructive sleep apnea, Obstructive Sleep Apnea (OSA)
Age 22years - 100years
Clinical Study IdentifierTX1033
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.